AxoGen sees FY19 revenue at least $106.6M, consensus $107.76M AXGN
AxoGen sees Q4 revenue at least $28.1M, consensus $29.22M AXGN
Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced preliminary unaudited fourth quarter and full-year 2019 re
ALACHUA, Fla., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Stock Analysts’ downgrades for Friday, January 10th: Advantage Oil & Gas (OTCMKTS:AAVVF) was downgraded by analysts at ValuEngine from a hold rating to a sell rating. Atlas Air Worldwide (NASDAQ:AAW
Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that its RANGER registry enrollment has r
Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced its participation at the combined 2020 me
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE